Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL88171 | 0.86 | — | — | |
| SCHEMBL11835527 | 0.83 | — | — | |
| SCHEMBL9248210 | 0.83 | — | — | |
| SCHEMBL10899385 | 0.83 | — | — | |
| SCHEMBL21416634 | 0.80 | MEN1 (0.34) | MEN1POLBKMT2A | |
| SCHEMBL11667239 | 0.79 | — | — | |
| SCHEMBL9806606 | 0.78 | ALDH1A1 (0.36) | MEN1POLBKMT2A | |
| SCHEMBL7164229 | 0.77 | — | — | |
| SCHEMBL10707995 | 0.77 | TSHR (0.37) | MEN1POLBKMT2A | |
| SCHEMBL27674548 | 0.76 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116606088-B | Ultraviolet-resistant asphalt mastic macadam mixture and preparation method thereof | 芜湖城瑞路桥建设有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-116606088-A | Ultraviolet-resistant asphalt mastic macadam mixture and preparation method thereof | 芜湖城瑞路桥建设有限公司 | 2023-08-18 | — | — | CN | claimed |
| CN-116606088-B | Ultraviolet-resistant asphalt mastic macadam mixture and preparation method thereof | 芜湖城瑞路桥建设有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-116606088-A | Ultraviolet-resistant asphalt mastic macadam mixture and preparation method thereof | 芜湖城瑞路桥建设有限公司 | 2023-08-18 | — | — | CN | disclosed |
| US-11316201-B2 | Additives to improve electrolyte performance in lithium ion battery | SOLVAY SA (BE) | 2022-04-26 | — | — | US | disclosed |
| CN-109705247-B | Flame-retardant polyolefin and preparation method thereof, and method for improving compatibility of polyolefin and flame retardant and simultaneously enhancing flame retardance of polyolefin | 中国科学技术大学 | 2020-05-12 | — | — | CN | disclosed |
| CN-109705247-A | The method that the compatibility of fire retardant polyolefin and preparation method thereof and improvement polyolefin and fire retardant enhances its anti-flammability simultaneously | 中国科学技术大学 | 2019-05-03 | — | — | CN | disclosed |
| US-20180301759-A1 | ADDITIVES TO IMPROVE ELECTROLYTE PERFORMANCE IN LITHIUM ION BATTERY | SOLVAY SA (BE) | 2018-10-18 | — | — | US | disclosed |
| US-10074874-B2 | Additives to improve electrolyte performance in lithium ion batteries | SOLVAY SA (BE) | 2018-09-11 | — | — | US | disclosed |
| US-9877908-B2 | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives | DUKE UNIVERSITY (US) | 2018-01-30 | — | — | US | disclosed |
| US-20170239160-A1 | COSMETIC AND PHARMACEUTICAL COMPOSITIONS AND METHODS USING 2-DECARBOXY-2-PHOSPHINICO DERIVATIVES | THE PROCTER & GAMBLE COMPANY | 2017-08-24 | — | — | US | disclosed |
| US-20070287644-A1 | LUBRICATING OIL COMPOSITION | SHELL OIL COMPANY | 2007-12-13 | — | — | US | disclosed |
| EP-1860175-A2 | Lubricating oil composition | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2007-11-28 | — | — | EP | disclosed |
| US-20060247214-A1 | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives | DUKE UNIVERSITY (US) | 2006-11-02 | — | — | US | disclosed |
| US-20060105924-A1 | Friction regulator for lubricating oil and lubricating oil composition | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2006-05-18 | — | — | US | disclosed |
| EP-1267806-B1 | USE OF COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING 2-DECARBOXY-2-PHOSPHINICO DERIVATIVES OF PROSTAGLANDINS | UNIV DUKE (US) | 2005-12-07 | — | — | EP | disclosed |
| EP-1489158-A1 | FRICTION REGULATOR FOR LUBRICATING OIL AND LUBRICATING OIL COMPOSITION | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2004-12-22 | — | — | EP | disclosed |
| EP-1267806-A2 | COSMETIC AND PHARMACEUTICAL COMPOSITIONS AND METHODS USING 2-DECARBOXY-2-PHOSPHINICO DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 2003-01-02 | — | — | EP | disclosed |
| US-20020013294-A1 | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives | DUKE UNIVERSITY | 2002-01-31 | — | — | US | disclosed |
| WO-2001074314-A2 | COSMETIC AND PHARMACEUTICAL COMPOSITIONS AND METHODS USING 2-DECARBOXY-2-PHOSPHINICO DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 2001-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247214-A1 | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives | BMP2, PLOD2, PTGDR2 | MEN1 1384/4885POLB 775/4885KMT2A 2935/4885 |
| US-20170239160-A1 | COSMETIC AND PHARMACEUTICAL COMPOSITIONS AND METHODS USING 2-DECARBOXY-2-PHOSPHINICO DERIVATIVES | BMP2, PLOD2, PTGDR2 | MEN1 1384/4885POLB 775/4885KMT2A 2935/4885 |
| US-20020013294-A1 | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives | BMP2, PLOD2, PTGDR2 | MEN1 1384/4885POLB 775/4885KMT2A 2935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.